Atrial flutter-related health care use and costs: An analysis of a nationally representative administrative claims database in the United States

[1]  Trevon D McGill,et al.  Single-Dose Intraprocedural Steroid Administration Does Not Impact Early Atrial Fibrillation Recurrence , 2021, Cardiovascular Drugs and Therapy.

[2]  S. Tepper,et al.  Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study , 2021, The Journal of Headache and Pain.

[3]  E. Benjamin,et al.  Epidemiology of Atrial Fibrillation in the 21st Century , 2020, Circulation research.

[4]  Jeroen J. Bax,et al.  2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). , 2019, European heart journal.

[5]  G. Lippi,et al.  Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge , 2020, International journal of stroke : official journal of the International Stroke Society.

[6]  Anna Julia Heymann,et al.  A diagnostic accuracy study validating cardiovascular ICD-9-CM codes in healthcare administrative databases. The Umbria Data-Value Project , 2019, PloS one.

[7]  Mary G. George,et al.  Emergency Department, Hospital Inpatient, and Mortality Burden of Atrial Fibrillation in the United States, 2006 to 2014. , 2017, The American journal of cardiology.

[8]  S. Hernández-Díaz,et al.  Matching Weights to Simultaneously Compare Three Treatment Groups: Comparison to Three-way Matching , 2017, Epidemiology.

[9]  Sudha Seshadri,et al.  50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study , 2015, The Lancet.

[10]  G. Lip,et al.  Risk of Bleeding and Stroke with Oral Anticoagulation and Antiplatelet Therapy in Patients with Atrial Fibrillation in Taiwan: A Nationwide Cohort Study , 2015, PloS one.

[11]  L. Chen,et al.  Impact of Atrial Fibrillation on Healthcare Utilization in the Community: The Atherosclerosis Risk in Communities Study , 2014, Journal of the American Heart Association.

[12]  G. Marcus,et al.  Healthcare Utilization and Clinical Outcomes after Catheter Ablation of Atrial Flutter , 2014, PloS one.

[13]  F. Gudé,et al.  Assessment of long-term quality of life after cavotricuspid isthmus ablation for typical atrial flutter , 2014, Health and Quality of Life Outcomes.

[14]  A. Amin,et al.  Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors , 2011, Advances in therapy.

[15]  S. Johnston,et al.  Estimation of Total Incremental Health Care Costs in Patients With Atrial Fibrillation in the United States , 2011, Circulation. Cardiovascular quality and outcomes.

[16]  H. Calkins,et al.  Meta-analysis of ablation of atrial flutter and supraventricular tachycardia. , 2010, The American journal of cardiology.

[17]  G. Naccarelli,et al.  Increasing prevalence of atrial fibrillation and flutter in the United States. , 2009, The American journal of cardiology.

[18]  B. Koplan,et al.  Cardiology patient page. Atrial flutter. , 2005, Circulation.

[19]  H. Calkins,et al.  Results of catheter ablation of typical atrial flutter. , 2004, The American journal of cardiology.

[20]  H. Wellens.  Contemporary Management of Atrial Flutter , 2002, Circulation.

[21]  R. Vierkant,et al.  Incidence and predictors of atrial flutter in the general population. , 2000, Journal of the American College of Cardiology.

[22]  Mark Payne,et al.  Health and Human Services , 2020, Congress and the Nation 2013-2016, Volume XIV: Politics and Policy in the 113th and 114th Congresses.

[23]  H. Calkins,et al.  2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2016, Journal of the American College of Cardiology.

[24]  C. Steiner,et al.  Comorbidity measures for use with administrative data. , 1998, Medical care.